MedWatch

Sofinnova raises EUR 472m for life science fund

Now is the time to invest in healthcare, says Sofinnova Partners, as it announces a new fund to back life science startups.

Photo: Antonio Bronic/Reuters/Ritzau Scanpix

The European venture capital firm Sofinnova, which specializes in life sciences and healthcare, has raised its tenth life science fund for startups in Europe, writes the European business media Sifted.

The life science fund has backed some unicorn companies – which is a startup valued at USD 1bn – like Ascendis Pharma, Shockwave and Actelion.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs